Bluebird Bio reported $676K in Ordinary Share Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acceleron Pharma XLRN:US $ 0.06M 0M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alexion Pharmaceuticals ALXN:US $ 0M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.19M 0.01M
Amgen AMGN:US $ 31877M 71M
Applied Genetic Technologies AGTC:US $ 0.04M 0.02M
Arrowhead Research ARWR:US $ 197K 1000
Avrobio Inc AVRO:US $ 4K 0
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bluebird Bio BLUE:US $ 0.68M 0M
Dicerna Pharmaceuticals DRNA:US $ 0.01M 0M
Immunogen IMGN:US $ 2M 0M
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
Mirati Therapeutics MRTX:US $ 0.05M 0M
Moderna Inc MRNA:US 0 0
Nektar Therapeutics NKTR:US $ 0.02M 0M
Novartis NOVN:VX SF 913M 0M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sangamo Biosciences SGMO:US $ 1.45M 0.01M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vertex Pharmaceuticals VRTX:US $ 2.59M 0M
YTE INCY:US $ 0.22M 0M